Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
neoantigen dna vaccine (1 trial)
tumor-pulsed dendritic cells (2 trials)
Melanoma (Phase 2)
Trials (3 total)
Trial APIs (2 total)